Last $6.55 USD
Change Today +0.09 / 1.39%
Volume 8.5M
ARIA On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 01/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David L. Berstein Esq.

Chief Intellectual Property Counsel and Senior Vice President, Ariad Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

62--

Background*

Mr. David L. Berstein, Esq. serves as Chief Intellectual Property Counsel at Ariad Pharmaceuticals Inc. Mr. Berstein has been Senior Vice President of Ariad Pharmaceuticals Inc. since June 2000 and also served as its General Counsel. Mr. Berstein served as the Chief Intellectual Property Officer at Ariad Pharmaceuticals Inc., since May 2008. He served as the Chief Patent Counsel of Ariad Pharmaceuticals Inc. since September 1993 until June 2007 and also served as its ...

Read Full Background

Corporate Headquarters*

26 Landsdowne Street
Cambridge, Massachusetts 02139

United States

Phone: 617-494-0400
Fax: 617-494-8144

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
University of Michigan
JD
Fordham University School of Law

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARIA:US $6.55 USD +0.09

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jack Lief Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Arena Pharmaceuticals, Inc.
$725.0K
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$548.8K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Adelene Q. Perkins Chairman of The Board, Chief Executive Officer and President
Infinity Pharmaceuticals, Inc.
$552.0K
Aijaz Tobaccowalla Managing Director, Additional Director, Member of Board Administrative Committee and Member of Nomination & Remuneration Committee
Pfizer Limited
30.3M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARIAD PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.